Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bahr

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Veterinary Research Communications|March 11, 2025
Typing of hemotropic Mycoplasma in Egyptian cats: first detection and phylogenetic analysis of Candidatus Mycoplasma turicensisMahmoud S Safwat, Noha M Bakry, Amany D Bahr, et al.
Cardiology|July 15, 2000
Combining necrosis and platelet markers for perfecting myocardial infarction rule out: how close are we?G V Nair, P A Gurbel, S Y Fuzaylov, et al.
Coronary Artery Disease|November 21, 1998
Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysisP A Gurbel, V L Serebruany, A R Shustov, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2003
Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy)Paul A Gurbel, Brian Galbut, Kevin P Bliden, et al.
The American Journal of Cardiology|December 15, 1991
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study GroupJ M Kirshenbaum, R D Bahr, J T Flaherty, et al.
Stroke|January 28, 1998
Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III InvestigatorsV L Serebruany, P A Gurbel, A R Shustov, et al.
The New England Journal of Medicine|December 24, 1987
A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplastyA D Guerci, G Gerstenblith, J A Brinker, et al.
Journal of the American College of Cardiology|January 15, 2002
Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable anginaSteven P Schulman, David R Thiemann, Pamela Ouyang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2024
Experimental coral reef communities transform yet persist under mitigated future ocean warming and acidificationChristopher P Jury, Keisha D Bahr, Annick Cros, et al.
Circulation|November 1, 1996
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trialS P Schulman, P J Goldschmidt-Clermont, E J Topol, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Veterinary Research Communications|March 11, 2025
Typing of hemotropic Mycoplasma in Egyptian cats: first detection and phylogenetic analysis of Candidatus Mycoplasma turicensisMahmoud S Safwat, Noha M Bakry, Amany D Bahr, et al.
Cardiology|July 15, 2000
Combining necrosis and platelet markers for perfecting myocardial infarction rule out: how close are we?G V Nair, P A Gurbel, S Y Fuzaylov, et al.
Coronary Artery Disease|November 21, 1998
Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysisP A Gurbel, V L Serebruany, A R Shustov, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2003
Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy)Paul A Gurbel, Brian Galbut, Kevin P Bliden, et al.
The American Journal of Cardiology|December 15, 1991
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study GroupJ M Kirshenbaum, R D Bahr, J T Flaherty, et al.
Stroke|January 28, 1998
Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III InvestigatorsV L Serebruany, P A Gurbel, A R Shustov, et al.
The New England Journal of Medicine|December 24, 1987
A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplastyA D Guerci, G Gerstenblith, J A Brinker, et al.
Journal of the American College of Cardiology|January 15, 2002
Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable anginaSteven P Schulman, David R Thiemann, Pamela Ouyang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2024
Experimental coral reef communities transform yet persist under mitigated future ocean warming and acidificationChristopher P Jury, Keisha D Bahr, Annick Cros, et al.
Circulation|November 1, 1996
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trialS P Schulman, P J Goldschmidt-Clermont, E J Topol, et al.
Pageof 5